2021 Investor Day
Well-positioned to improve quality of life and transform healthcare
Healthcare spending as a
percentage of GDP is expanding
ResMed digital health assets can
lower long-term cost of care and
chronic disease progression
Shifting mindset of plan providers:
focus on long-term total cost of care
Poor respiratory health driven by air
quality issues in developing
economies
Chronic health issues driven by
aging populations in industrial
economies
Our leading position in sleep and
respiratory data is a key advantage toward
this accelerating dynamic
Our global footprint and recognized
leadership in respiratory care enable us to
address health crisis issues
Evidence identified / supported by our data-
rich ecosystem helps to proactively treat
chronic conditions and improve quality of life
Leveraging our leadership
position and capabilities to
improve the lives of
~1.6B people
with undiagnosed sleep apnea,
COPD, or asthma
936M
with sleep apnea
380M
with COPD
330M
with asthma
© 2021 ResMed | 2021 Investor Day - Sept 8, 2021
ResMed technology improves outcomes and patients' lives
13View entire presentation